Skip to content

Evolv Technologies Holdings, Inc. EVLV Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value at other companies

Repligen logo
RepligenRGEN
$155.80
AMN Healthcare logo
AMN HealthcareAMN
$80.79-9.9%
Heartland Express logo
Heartland ExpressHTLD
$10.71-5.1%
Cal-Maine Foods logo
Cal-Maine FoodsCALM
$54.10+21.0%
Heartland Express logo
Heartland ExpressHTLD
$10.48-4.3%
Repligen logo
RepligenRGEN
$129.34

Other financials

Income statement

See full
Revenue$46.3M+44.7%
Gross profit$23.6M+23.2%
Operating income-$8.5M+41.1%
Net income-$5.0M-197%
EPS (diluted)-$0.03-200%

Balance sheet

See full
Cash & equivalents$56.1M+124%
Total debt$42.0M+191%
Total equity$120.7M-0.3%
Total assets$304.6M+19.0%

Cash flow

See full
Operating cash flow-$3.2M-25.2%
CapEx$6.4M+107%
Free cash flow-$9.6M-70.0%

Valuation

See full
Market cap$987.49M+0.1%
Enterprise value$973.38M-0.3%
P/S6.2×-2.5×

Profitability

See full
Gross margin49.8%-8.7pp
Operating margin-26.6%-9.9pp
Net margin-43.8%-8.7pp
FCF margin6.9%

Returns & leverage

See full
Return on equity-51.7%+24.4pp
Debt / equity0.3×+0.2×
Current ratio1.2×+0.1×

Where this comes from

Reported directly by Evolv Technologies Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.

The official record: Evolv Technologies Holdings, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolv Technologies Holdings, Inc.'s share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolv Technologies Holdings, Inc.'s share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value?
Evolv Technologies Holdings, Inc. (EVLV) reported share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value of $6.77 in Q1 2026.